The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.
about
Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significanceInterferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancerOncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis.Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC).Prognostic relevance of miR-137 in patients with hepatocellular carcinoma.N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cells.Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma.
P2860
Q34606618-13185D2B-3E9B-44D6-8B68-D5B69C124F8AQ36971961-B674FBFB-7710-4048-B706-199A203BA6D6Q37468314-39CAC60D-ECDC-47E1-B9E2-E33F8FE7A99BQ38552480-5DABCD08-E306-4DE7-B336-387540168C26Q38872768-F3829F60-56BD-4960-BE09-070BA780D4FCQ38954672-DA86F64B-F52D-4AEF-8AFD-9702A44657D5Q38999896-D7508F67-0074-402D-8A4E-6FBA5DD915EBQ39544347-5652DAA0-7997-4C66-882D-52A76DC1AE07Q41880643-38B16B64-2CA0-4D7D-860C-7C133818EC2CQ44365724-ABF3E7EC-1FEB-4E66-B247-B40DA3BF949E
P2860
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The cancer stem cell marker CD ...... nced hepatocellular carcinoma.
@en
The cancer stem cell marker CD ...... nced hepatocellular carcinoma.
@nl
type
label
The cancer stem cell marker CD ...... nced hepatocellular carcinoma.
@en
The cancer stem cell marker CD ...... nced hepatocellular carcinoma.
@nl
prefLabel
The cancer stem cell marker CD ...... nced hepatocellular carcinoma.
@en
The cancer stem cell marker CD ...... nced hepatocellular carcinoma.
@nl
P2093
P2860
P1476
The cancer stem cell marker CD ...... nced hepatocellular carcinoma.
@en
P2093
Ah-Mee Park
Hiroshi Munakata
Hobyung Chung
Kazuomi Ueshima
Kazuto Nishio
Mami Yamaguchi
Masahiro Takita
Masatomo Kimura
Satoru Hagiwara
Seiji Haji
P2860
P304
P356
10.1007/S00535-010-0294-5
P577
2010-08-04T00:00:00Z